2 active not recruiting, 1 suspended. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Suspended 1 |
| Phase 2 | 3 | Active not recruiting 2, Suspended 1 |
Follow Intralytix, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects VRELysin™, Placebo - Vancomycin-Resistant Enterococcal Colonization | Phase 1 / Phase 2 | Suspended | Intralytix, Inc. | 80 | 2023-10-25 | 2026-04-14 |
| Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis bacteriophage, Placebo - Shigellosis | Phase 1 / Phase 2 | Active not recruiting | Intralytix, Inc. | 52 | 2023-02-23 | 2025-06-15 |
| Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease Placebo, Bacteriophage preparation - Crohn Disease | Phase 1 / Phase 2 | Active not recruiting | Intralytix, Inc. | 30 | 2019-05-01 | 2025-06-15 |
Crohn Disease (1) · Dysentery, Bacillary (1)
Saline Solution (1)
United States (3)
Alexander Sulakvelidze, PhD (1) · Minh-Hong Nguyen, MD (1) · Reezwana Chowdhury, MD (1) · Robert Hirten, MD (1) · Wilbur Chen Chen, MD, MS (1)